Physician profile
Ankur Lodha
NPI 1598951436
$640,437.37
in general payments reported to CMS, 2019-2025
54 companies · $142K in 2025
The $142K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84K · 2020: $43K · 2021: $63K · 2022: $98K · 2023: $76K · 2024: $136K · 2025: $142K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $173K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $63K · Travel and Lodging: $45K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38K · Food and Beverage: $21K · Honoraria: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $173,047.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $62,700.00 |
| Travel and Lodging | $44,776.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,962.50 |
| Food and Beverage | $21,159.37 |
| Honoraria | $13,025.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $158,255.74 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Medical L6 Intravascular Lithotripsy (Ivl) Catheter |
| Terumo Medical Corporation | $140,924.28 | 2019-2025 | Glidesheath Slender, Navicross, R2p Misago |
| Cardiovascular Systems INC. | $82,934.44 | 2019-2023 | Diamondback Peripheral |
| Boston Scientific Corporation | $73,461.16 | 2019-2025 | General - Therapies, Sterling, Ranger |
| Surmodics, INC. | $50,390.83 | 2020-2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Sublime Microcatheter, 014, 65cm, Straight |
| Silk Road Medical, INC. | $44,322.75 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Angiodynamics, INC. | $22,799.18 | 2023-2025 | Alphavac, Angiovac, Auryon Laser System 100-120 Vac |
| W. L. Gore & Associates, INC. | $15,658.67 | 2022-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Asahi Intecc USA, INC. | $14,463.85 | 2019-2025 | Peripheral Vascular, Asahi Peripheral Vascular Wires |
| Cordis US Corp. | $8,723.88 | 2021-2025 | Selution Slrptca, Brite Tip Radianz, Saber |
| Abbott Laboratories | $5,756.14 | 2019-2025 | Diamondback Peripheral, Diamondback Coronary |
| Penumbra, INC. | $4,650.38 | 2020-2024 | Indigo System, Smart Coil |
| Bard Peripheral Vascular, INC. | $3,115.83 | 2019-2024 | Venclose Maven Catheter |
| Inari Medical, INC. | $3,049.85 | 2019-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $2,420.62 | 2021-2025 | Mo.Ma Ultra, Venaseal, Abre |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $2,258.85 | 2019-2025 | (6554) Periph Vasc Undiv, (6554) Peripheral Vascular Undivided, Eagle Eye |
| Abiomed | $2,119.78 | 2019-2025 | Impella |
| Medicure Pharma INC. | $700.00 | 2020-2021 | |
| Corindus INC. | $579.30 | 2019 | |
| Pfizer INC. | $500.31 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $490.21 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $456.70 | 2019-2025 | |
| Novo Nordisk INC | $366.25 | 2024-2025 | Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $274.08 | 2021-2025 | Jardiance |
| Csl Behring | $169.97 | 2019 | |
| Veryan Medical Incorporated | $157.47 | 2021 | |
| Merck Sharp & Dohme LLC | $133.15 | 2021-2023 | Verquvo |
| Cook Medical LLC | $131.86 | 2022 | |
| Amgen INC. | $113.48 | 2020-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $110.80 | 2022-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $99.81 | 2019-2020 | |
| Scpharmaceuticals INC. | $78.08 | 2024-2025 | |
| Becton, Dickinson and Company | $77.67 | 2023-2024 | Venclose Maven Catheter, Venovo |
| Imperative Care, INC | $72.51 | 2025 | Symphony Catheter, Prodigy Catheter |
| Siemens Medical Solutions USA, INC. | $65.21 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64.32 | 2020-2023 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $58.44 | 2022 | |
| Contego Medical, INC | $51.95 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $51.73 | 2025 | Evkeeza |
| Mimedx Group, INC. | $46.30 | 2025 | |
| Inspiremd Ltd | $40.00 | 2023 | Cguard |
| Vesper Medical | $29.50 | 2021 | |
| Portola Pharmaceuticals, LLC | $28.83 | 2019 | |
| Gilead Sciences, INC. | $25.89 | 2019 | |
| Cardiva Medical, INC. | $24.12 | 2021 | |
| Stryker Corporation | $22.67 | 2025 | Artix Mt |
| Kiniksa Pharmaceuticals International, Plc | $21.11 | 2024 | Arcalyst |
| Lundbeck LLC | $17.03 | 2019 | |
| Chiesi USA, INC. | $16.91 | 2019 | |
| Argon Medical Devices, INC. | $15.67 | 2024 | Clot Management |
| Kowa Pharmaceuticals America, INC. | $15.59 | 2020 | |
| Reflow Medical INC | $12.40 | 2023 | |
| Qapel Medical INC | $11.82 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$70,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankur Lodha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.